Effect of tetrahydroaminoacridine, a cholinesterase inhibitor, on cognitive performance following experimental brain injury

Journal of Neurotrauma

Volumn 14, Issue 12, 1997, Pages 897-905

  Pike, Brian R ^a   Hamm, Robert J ^a,b   Temple, Meredith D ^a   Buck, Deanna L ^a   Lyeth, Bruce G ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Cholinergic; Cholinesterase; Morris water maze; Muscarinic; Rats; Tacrine (THA); Traumatic brain injury; Treatment

Indexed keywords

CHOLINESTERASE INHIBITOR; TACRINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INJURY; COGNITION; CONTROLLED STUDY; DOSE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; LATENT PERIOD; MALE; MAZE TEST; NONHUMAN; RAT; TASK PERFORMANCE;

EID: 0031407173     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.1997.14.897     Document Type: Article

References (71)

1. ALBIN, R.L., YOUNG, A.B., and PENNEY, J.B. (1988). Tetrahydro-9-aminoacridine (THA) interacts with the phencyclidine (PCP) receptor site. Neurosci. Lett., 88, 303-307.
2. ALONSO, R., KAN, J.P., WORMAS, P., and SOUBRIE, P. (1990). Effects of repeated administration of tetrahydroaminoacridine (THA) on muscarinic receptor subtypes in the rat brain. Neurochem. Int. 17, 457-465.
3. BECKER, R.E., and GIACOBINI, E. (1988). Mechanisms of cholinesterase inhibition in senile dementia of the Alzheimer's type: Clinical, pharmacological, and therapeutic aspects. Drug Dev. Res. 12, 163-195.
4. BROOKS, N., MCKINLAY, W., SYMINGTON, C., BEATTIE, A., and CAMPSIE, L. (1987). Return to work within the first seven years of severe head injury. Brain Injury 1, 5-19.
5. BUYUKUYSAL, R.L., and WURTMAN, R.J. (1989). Tetrahydroaminoacridine but not 4-aminopyridine inhibits high-affinity choline uptake in striatal and hippocampal synaptosomes. Brain Res. 482, 371-375.
6. CAPRUSO, D.X., and LEVIN, H.S. (1992). Cognitive impairment following closed head injury. Neurol. Clin. 10(4), 879-893.
7. CHOU, C.L., LYETH, B.G., JENKINS, L.W., HAYES, R.L., and POVLISHOCK, J.T. (1991). Regional cerebral blood flow changes after traumatic brain injury in the rat. Soc. Neu-rosci. Abstr. 17, 722.
8. DAVIS, K.L., THAL, L.T., GAMZU, E.R. et al. (1992). A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. N. Engl. J. Med. 327, 1253-1259.
9. DEWITT, D.S., HAYES, R.L., LYETH, B.G., YUAN, X.Q., and PROUGH, D.S. (1988). Effects of traumatic brain injury on cerebral blood flow and metabolism: Autoradiographic studies. Anesthes. Rev. 15, 31-32.
10. DIXON, C.E., BAO, J., JOHNSON, K.M., YANG, K., WHITSON, J., CLIFTON, G.L., and HAYES, R.L. (1995a). Basal and scopolamine-evoked release of hippocampal acetylcholine following traumatic brain injury in rats. Neurosci. Lett. 198, 111-114.
11. DIXON, C.E., FLINN, P., BAO, J., YANG, K., WHISON, G.L., CLIFTON, G.L., and HAYES, R.L. (1995b). Nerve growth factor (NGF) reduces decreases in spatial memory performance and choline acetyltransferase (ChAT) immunoreactivity in the medial septal area following traumatic brain injury. Soc. Neurosci. Abstr. 21, 762.
12. DIXON, C.E., HAMM, R.J., TAFT, W.C., and HAYES, R.L. (1994). Increased anticholinergic sensitivity following closed skull impact and controlled cortical impact traumatic brain injury. J. Neurotrauma 11, 275-287.
13. DIXON, C.E., LIU, S., JENKINS, L.W., BHATTACHARGEE, M., WHITSON, J.S., YANG, K., and HAYES, R.L. (1995c). Time course of increased vulnerability of cholinergic neurotransmission following traumatic brain injury in the rat. Behav. Brain Res. 70, 125-131.
14. DIXON, C.E., LYETH, B.C., POVLISHOCK, J.T. et al. (1987). A fluid percussion model of experimental brain injury in the rat. J. Neurosurgery 67, 110-119.
15. DOODS, H., ENTZEROTH, M., ZIEGLER, H. et al. (1993a). Characterization of BIBN 99: A lipophilic and selective muscarinic M2 receptor antagonist. Eur. J. Pharmacol. 242, 23-30.
16. 2 antagonists as potential drugs for cognitive disorders. Drugs Fut. 20, 157-164.
17. 2 antagonists: Novel structures and pharmacology. Life Sci. 52, 497-503.
18. BAGGER, S., MORANT, N., LEVY, R., and SAHAKIAN, B. (1992). Tacrine in Alzheimer's disease. Time course of changes in cognitive function and practice effects. Br. J. Psychiatry, 160, 36-40.
19. ENZ, A., AMSTUTZ, R., BODDEKE, H., GMELIN, G., and MALANOWSKI, J. (1993). Brain selective inhibition of acetylcholinesterase: A novel approach to therapy for Alzheimer's disease. Prog. Brain Res. 98, 431-438.
20. FARLOW, M., GRACON, S.I., HERSHEY, L.A., LEWIS, K.W., SADOWSKY, C.H., and DOIAN-URENO, J. (1992). A controlled trial of tacrine in Alzheimer's disease. JAMA 268, 2523-2529.
21. FLOOD, J.F., LANDRY, D.W., and JARVIK, M. (1981). Cholinergic receptor interactions and their effects on long-term processing. Brain Res. 215, 177-185.
22. FLYNN, D.D., and MASH, D.C. (1989). Multiple in vivo interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine. J. Pharmacol. Exp. Ther. 250, 573-581.
23. FORTUNA, S., PINTOR, A., NALEPA, I., and MICHALEK, H. (1994). Altered modulation by excitatory amino acids of cortical phosphatidylinositol system stimulated by carbachol in rats poisoned by an anti-cholinesterase compound, diisopropyl fluorophosphate. Neurotoxicology 15, 735-740.
24. GAITHIER, S., BOUCHARD, R., LAMONTAGNE, A. et al. (1990). Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate-stage Alzheimer's disease. Results of a Canadian Double-Blind, Crossover Multicenter Study. N. Engl. J. Med. 322, 1272-1276.
25. GAITHER, S., GAITHIER, L., BOUCHARD, R., QUIRION, R., and SULTAN, S. (1991). Treatment of Alzheimer's disease: Hopes and reality. Can. J. Neurol. Sci. 18, 439-441.
26. GRADY, M.S., LEONARD, J., and MARIS, D.O. (1992). Lateral fluid percussion brain injury causes cholinergic forebrain neuron death. Soc. Neurosci. Abstr. 18, 172.
27. GRAY, J.A., ENZ, A., and SIEGEL, R. (1989). Muscarinic agonists for senile dementia: Past experience and future trends. Trends Pharmacol. Sci. 10 (Suppl.), 85-87.
28. HAMM, R.J., LYETH, B.C., JENKINS, L.W., O'DELL, D.M., and PIKE, B.R. (1993). Selective cognitive impairment following traumatic brain injury in rats. Behav. Brain Res. 59, 169-173.
29. HAMM, R.J., PIKE, B.R., O'DELL, D.M., LYETH, B.C., and JENKINS, L.W. (1994). The rotarod test: An evaluation of its effectiveness in assessing motor deficits following traumatic brain injury. J. Neurotrauma 11, 187-196.
30. HAMM, R.J., PIKE, B.R., O'DELL, D.M., and LYETH, B.G. (1994). Traumatic brain injury enhances the amnesic effect of a NMDA antagonist in rats. J. Neurosurg. 81, 267-271.
31. HAMM, R.J., WHITE-GBADEBO, D., LYETH, B.G., JENKINS, L.W., and HAYES, R.L. (1992). The effect of age on motor and cognitive deficits after traumatic brain injury in rats. Neurosurgery 31, 1072-1078.
32. HAROUTUNIAN, V., BARNES, E., and DAVIS, K.L. (1985). Cholinergic modulation of memory in rats. Psychopharmacology 87, 266-271.
33. HODGES, H., RIBEIRO, A.M., GRAYY, J.A., and MARCHBANKS, R.M. (1990). Low dose tetrahydroaminoacridine (THA) improves cognitive function but does not affect brain acetylcholine in rats. Pharmacol. Biochem. Behav. 36, 291-298.
34. KIEFER-DAY, J.S., and EL-FAKAHANY, E.E. (1992). Muscarinic receptor function and acetylcholinesterase activity after chronic administration of tacrine to mice at therapeutic drug concentrations. Pharmacology 44, 71-80.
35. KNAPP, M.J., KNOPMAN, D.S., SOLOMON, P.R., PENDLEBURY, W.W., DAVIS, C.S., and GRACON, S.I. (1994). A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. JAMA 271, 985-991.
36. KWO-ON-YEUN, P.P., MANDEL, R., CHEN, A.D., and THAL, L.J. (1990). Tetrahydroaminoacridine improves the spatial deficit produced by nucleus basalis lesions in rats. Exp. Neurol. 108, 221-228.
37. LEONARD, J.R., MARIS, D.O., and GRADY, M.S. (1994). Fluid percussion injury causes loss of forebrain choline acetyltransferase and nerve growth factor receptor immunoreactive cells in the rat. J. Neurotrauma 11, 379-392.
38. LEVIN, H. (1992). Neurobehavioral recovery. J. Neurotrauma 9 (Suppl. 1), S359-S373.
39. LIU, S.J., DIXON, C.E., and HAYES, R.L. (1993). The effects of varying doses of CDP-choline on recover of spatial memory function following controlled cortical impact injury in rats. Soc. Neurosci. Abstr. 19, 1881.
40. LYETH, B.G., DIXON, C.E., HAMM, R.J. et al. (1988). Effects of anticholinergic treatment on transient behavioral suppression and physiological responses following concussive brain injury to the rat. Brain Res. 448, 88-97.
41. LYETH, B.G., JENKINS, L.W., HAMM, R.J. et al. (1990). Prolonged memory impairment in the absence of hippocampal cell death following traumatic brain injury in the rat. Brain Res. 526, 249-258.
42. 2 muscarinic receptors. J. Pharmacol. Exp. Ther. 248, 1255-1260.
43. MOLLOY, W.D., GUYATT, G.H., WILSON, D.B., DUKE, R., REES, L., and SINGER, J. (1991). Effect of tetrahydroaminoacridine on cognition, function and behavior in Alzheimer's disease. Can. Med. Assoc. J. 144, 29-34.
44. MOLTZEN, E.K., and BJORNHOLM, B. (1995). Medicinal chemistry of muscarinic agonists: Developments since 1990. Drugs Fut. 20, 37-54.
45. MORRIS, R.G.M. (1981). Spatial localization does not require the presence of local cues. Learning and Motivat. 12, 239-260.
46. 2 muscarinic receptor proteins with asymmetric synapsis in the primate cerebral cortex: Morphological evidence for cholinergic modulation of excitatory neurotransmission. Proc. Natl. Acad. Sci. 90, 5194-5198.
47. NIELSON, J.A., MENA, E.E., WILLIAMS, I.H., NOCERINI, M.R., and LISTON, D. (1989). Correlation of brain levels of 9-amino-1,2,3,4-tetrahydroacridine (THA) with neurochemical and behavioral changes. Eur. J. Pharmacol. 173, 53-64.
48. ODDY, M., COUGHLAN, T., TYERMAN, A., and JENKINS, D. (1985). Social adjustment after closed head injury: A further follow-up seven years after injury. J. Neurol. Neurosurg. Psychiatry 48, 564-568.
49. O'DELL, D.M., and HAMM, R.J. (1995). Chronic post-injury administration of Suritozole, a negative modulator at the GABA receptor, attenuates cognitive impairment in rats following traumatic brain injury. J. Neurosurgery 83, 878-883.
50. PIERCE, J.E.S., SMITH, D.H., EISON, M.S., and MCINTOSH, T.K. (1993). The nootropic compound BMY-21502 improves spatial learning ability in brain injured rats. Brain Res. 624, 199-208.
51. PIERCE, J.E.S., SMITH, D.H., TROJANOWSKI, J.Q., and MCINTOSH, T.K. (1994). Long-term behavioral sequelae of lateral fluid-percussion brain injury in the rat. Soc. Neurosci. Abstr. 20, 196.
52. 2 receptor antagonist, improves cognitive performance following traumatic brain injury in rats. Brain Res. 686, 37-43.
53. PIKE, B.R., and HAMM, R.J. (1997). Activating the post-traumatic cholinergic system for the treatment of cognitive impairment following traumatic brain injury. Pharm. Biochem. Behav. 57, 785-791.
54. PINTOR, A., FORTUNA, S., and MICHALEK, H. (1994). Carbachol-induced accumulation of inositol phosphates and its modulation by excitatory amino acids in cortical slices of young and aged rats with downregulation of muscarinic M-1 receptors. Neurochem. Res. 19, 1311-1317.
55. 2 receptors: Ligands, autoradiography and functions. Trends Pharmacol. Sci. 5 (Suppl.), 22-31.
56. 3 receptors. Brit. J. Pharmacol. 99, 753-761.
57. RIEKKINEN, P., AALTONEN, M., SIRVIO, J., and RIEKKINEN, P. (1991). Tetrahydroaminoacridine alleviates medial septa) lesion-induced and age-related spatial references but not working memory deficits. Physiol. Behav. 49, 1147-1152.
58. RIEKKINEN, P., SIRVIO, J., and RIEKKINEN, P. (1990). The effects of THA on medial septal lesion-induced memory deficits. Pharmacol. Biochem. Behav. 36, 237-241.
59. SANTUCCI, A.C., KANOF, P.D., and HAROUTUNIAN, V. (1989). Effect of physostigmine on memory consolidation and retrieval processes in intact and nucleus basalis-lesioned rats. Psychopharmacology 99, 70-74.
60. SARTER, M., BRUNO, J.P., and DUDCHENKO, P. (1990). Activating the damaged basal forebrain cholinergic system: Tonic stimulation versus signal amplification. Psychopharmacology 101, 1-17.
61. SCHMIDT, R.H., and GRADY, M.S. (1995). Loss of forebrain cholinergic neurons following fluid-percussion injury: Implications for cognitive impairment in closed head injury. J. Neurosurg. 83, 496-502.
62. SCHMITTER-EDGECOMBE, M.E., MARKS, W., FAHY, J.F., and LONG, C.J. (1992). Effects of severe closed-head injury on three stages of information processing. J. Clin. Exp. Neuropsychol. 14, 717-737.
63. SINSON, G., FLAMM, E.S., and MCINTOSH, T.K. (1995). Nerve growth factor attenuates the loss of cholinergic neurons in the medial septal nucleus which occurs after fluid-percussion brain injury in the rat. Soc. Neurosci. Abstr. 21, 2121.
64. SMITH, D.H., OKIYAMA, K., THOMAS, M.J., CLAUSSEN, B., and MCINTOSH, T.K. (1991). Evaluation of memory dysfunction following experimental brain injury using the Morris water maze. J. Neurotrauma 8, 259-269.
65. SUMMERS, W.K., MAJOVSKI, L.V., MARSH, G.M., TACHIKI, K., and KLING, A. (1986). Oral tetrahydroarainoacridine in ling-term treatment of senile dementia. N. Engl. J. Med. 315, 1241-1245.
66. TEMPLE, M.D., and HAMM, R.J. (1996). Chronic, post-injury administration of D-cycloserine, an NMDA partial agonist, enhances cognitive performance following experimental brain injury. Brain Res. 741, 246-251.
67. UEKI, A., and MIYOSHI, K. (1989). Effects of cholinergic drugs on learning impairment in ventral globus pallidus lesioned rats. J. Neurol. Sci. 90, 775-784.
68. 2 receptor mRNA expression and receptor binding in cholinergic and noncholinergic cells in rat brain: A collaborative study using in situ hybridization histochemistry and receptor autoradiography. Neurosci. 2, 367-393.
69. VIZI, E.S., KOBAYASHI, O., TÖRÖCSIK, A. et al. (1989). Heterogeneity of presynaptic muscarinic receptors involved in modulation or transmitter release. Neurosci. 31, 259-267.
70. WALKER, T.M., STARR, B., DEWHURST, B.B., and ATTERWILL, C. (1995). Potential neurotoxicity of a nobel aminoacridine analogue. Hum. Exp. Toxicol. 14, 469-474.
71. WHITEHOUSE, P.J. (1988). Intraventricular bethanechol in Alzheimer's disease. Neurology 38, 307-308.